These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31385978)

  • 21. Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
    Coomans MB; Dirven L; Aaronson NK; Baumert BG; Van Den Bent M; Bottomley A; Brandes AA; Chinot O; Coens C; Gorlia T; Herrlinger U; Keime-Guibert F; Malmström A; Martinelli F; Stupp R; Talacchi A; Weller M; Wick W; Reijneveld JC; Taphoorn MJB
    Neuro Oncol; 2019 Nov; 21(11):1447-1457. PubMed ID: 31682733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30.
    Regnault A; Pompilus F; Ciesluk A; Mazerolle F; Bejar R; Fram RJ; Faller DV; Marquis P; Bell JA
    J Patient Rep Outcomes; 2021 Jul; 5(1):60. PubMed ID: 34283303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran.
    Khoshnevisan A; Yekaninejad MS; Ardakani SK; Pakpour AH; Mardani A; Aaronson NK
    Health Qual Life Outcomes; 2012 May; 10():54. PubMed ID: 22607028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health related quality of life (HRQOL) in long-term survivors of pediatric low grade gliomas (LGGs).
    Nwachukwu CR; Youland RS; Chioreso C; Wetjen N; NageswaraRao A; Keating G; Laack NN
    J Neurooncol; 2015 Feb; 121(3):599-607. PubMed ID: 25467557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
    Grande GE; Farquhar MC; Barclay SI; Todd CJ
    Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients' experience of recurrent/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative study.
    Degboe A; Knight SL; Halling K; Trigg A; Al-Zubeidi T; Aldhouse N; Kitchen H; Wirth L; Rogers SN
    J Patient Rep Outcomes; 2017; 2():33. PubMed ID: 30148250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the acceptability, reliability, and validity of the EORTC Quality of Life Questionnaire (QLQ-C30) in Kenyan cancer patients: a cross-sectional study.
    Davda J; Kibet H; Achieng E; Atundo L; Komen T
    J Patient Rep Outcomes; 2021 Jan; 5(1):4. PubMed ID: 33415528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients.
    Mol L; Ottevanger PB; Koopman M; Punt CJ
    Eur J Cancer; 2016 Oct; 66():138-43. PubMed ID: 27573427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.
    Lee YJ; Suh SY; Choi YS; Shim JY; Seo AR; Choi SE; Ahn HY; Yim E
    Support Care Cancer; 2014 Jul; 22(7):1941-8. PubMed ID: 24577883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
    Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
    Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
    BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting.
    Renovanz M; Hechtner M; Janko M; Kohlmann K; Coburger J; Nadji-Ohl M; König J; Ringel F; Singer S; Hickmann AK
    J Neurooncol; 2017 Jul; 133(3):653-662. PubMed ID: 28527007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.
    Apolone G; Filiberti A; Cifani S; Ruggiata R; Mosconi P
    Ann Oncol; 1998 May; 9(5):549-57. PubMed ID: 9653497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updated EORTC QLQ-C30 general population norm data for Germany.
    Nolte S; Waldmann A; Liegl G; Petersen MA; Groenvold M; Rose M;
    Eur J Cancer; 2020 Sep; 137():161-170. PubMed ID: 32777715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.